Back

Risk of cerebrovascular events in patients after left atrial appendage closure: results from large, real-world dataset

12 April 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Left atrial appendage closure Left Atrial Appendage Closure EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Abhishek Maan

University of Toledo, Toledo (United States of America)

6 More presentations in this session

Presentation thumbnail
Outcomes for haemorrhagic transformation patients treated with left atrial appendage occlusion
Professor A. Sabbag (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Application of deep learning models to transesophageal echocardiography images for percutaneous left atrial appendage closure
Doctor R. Tateishi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Temporal morphological changes of the left atrial appendage after electrical isolation: implications for optimal timing of LAA occlusion
Doctor M. Tanaka (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Mechanical thrombus aspiration as a bailout strategy for device related thrombus after LAAC
Doctor V. La Fazia (Austin, US)
Abstract Slides Video
Presentation thumbnail
Clinical practice in left atrial appendage closure with focus on antithrombotic therapy: results from a European Heart Rhythm Association survey
Doctor L. Urbanek (Frankfurt, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Left atrial appendage closure

The Event

Event poster

EHRA 2026

12 April 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between CT findings and cardiac events during follow-up after percutaneous left atrial appendage closure
thumbnail
Congress Presentation
Left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter case-control study
thumbnail
Congress Presentation
Left atrial appendage closure in patients with ischemic stroke despite optimal oral anticoagulation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources